Approval for the advia centaur anti-hbs readypack reagents and advia centaur anti-hbs readypack calibrators.  The device is indicated for the qualitative determination of total antibodies to hepatitis b surface antigen in human serum or plasma (edta or heparinized) using the advia centaur system.  The assay results may be used as an aid in the determination of susceptibility to hepatitis b virus (hbv) infection in individuals prior to or following hbv vaccination or where vaccination status is unknown.  Assay results may be used with other hbv serological markers for the laboratory diagnosis of hbv  disease associated with hbv infection.  A reactive assay result will allow a differential diagnosis in individuals displaying signs and symptoms of hepatitis in whom etiology in unknown.